|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 403/04 | (2006.01) | ||
| C07D 403/14 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3072890 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14168117.1 |
| Date of filing the European patent application | 2010-07-06 | |
| (97) | Date of publication of the European application | 2016-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 223684 P | 2009-07-07 | US | |
| 247448 P | 2009-09-30 | US | |
| 318195 P | 2010-03-26 | US |
| (72) |
REWCASTLE, Gordon Wiliam, NZ
TSANG, Kit, Yee, NZ
GAMAGE, Swarnalatha, Akuratiya, NZ
GIDDENS, Anna, Claire, NZ
|
| (73) |
MEI Pharma, Inc.,
3611 Valley Centre Drive, Suite 500, San Diego, CA 92130,
US
|
| (54) | Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |